查看购物车
  • Traditional Chinese
  • English
MEA 呼吸道感染治疗市场规模和预测、区域份额、趋势和成长机会分析报告涵盖范围：按药物、疾病适应症、给药途径、年龄层、配销通路和国家/地区
市场调查报告书
商品编码
1463834

MEA 呼吸道感染治疗市场规模和预测、区域份额、趋势和成长机会分析报告涵盖范围：按药物、疾病适应症、给药途径、年龄层、配销通路和国家/地区

MEA Respiratory Tract Infection Treatment Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug, Disease Indication, Route of Administration, Age Group, Distribution Channel, and Country
出版日期: | 出版商: The Insight Partners | 英文 201 Pages | 订单完成后即时交付

价格

MEA呼吸道感染治疗市场规模预计将从2023年的20.9亿美元成长到2031年的29.7亿美元；预计2023年至2031年复合年增长率为4.50%。

治疗呼吸道感染的非处方药产品需求激增 MEA 呼吸道感染治疗市场的成长机会

大量消费者寻求针对咳嗽、鼻塞和喉咙痛等常见呼吸道症状的便利解决方案。这种方法使没有​​患有危及生命的疾病的个人能够密切监测和控制他们的健康。它还允许製造商、药房和医疗保健提供者使其产品更适合非处方药 (OTC) 应用，教育消费者进行自我保健实践，并改善获得缓解各种症状的治疗选择的机会。非处方呼吸疗法的快速普及凸显了提高呼吸健康意识、培养自我管理策略和协作医疗生态系统的重要性。透过利用非处方呼吸道产品的日益普及，中东和非洲地区的呼吸道感染治疗市场利益相关者可以提高患者参与度，推广预防性医疗保健措施，并满足不同人群不断变化的医疗保健需求。因此，对治疗呼吸道感染的非处方药产品的需求不断增长，为 MEA 呼吸道感染治疗市场带来了重大机会。

基于药物的见解

在药品方面，抗生素细分市场在 2023 年占据最大的 MEA 呼吸道感染治疗市场份额。呼吸道感染包括一系列疾病，包括支气管炎、肺炎和鼻窦炎，通常由细菌病原体引起。

基于疾病适应症的见解

根据疾病迹象，下呼吸道感染细分市场将在 2023 年占据更大的市场份额。通常由细菌、病毒或真菌病原体等引起。

基于给药途径的见解

从给药途径来看，口服细分市场在MEA呼吸道感染治疗市场中占有较大份额；预计同一细分市场在 2023 年至 2031 年期间将出现更高的复合年增长率。经常使用阿莫西林、阿奇霉素或多西环素等口服抗生素来对抗引起呼吸道感染的细菌病原体。

基于年龄组的见解

就年龄层而言，2023年成人细分市场在MEA呼吸道感染治疗市场中占有较大份额。儿童呼吸道感染的高盛行率是推动有效治疗方案需求的关键因素。

基于配销通路的见解

就配销通路而言，医院药房业务预计将在 2023 年至 2031 年期间占据重要的市场份额。医院药房是医疗保健系统的关键组成部分；它们在治疗需要静脉或肌肉注射药物的急性和严重呼吸道感染方面尤其发挥着至关重要的作用。

在准备 MEA 呼吸道感染治疗市场报告时提到的一些主要一手和二手来源包括杜拜卫生局、沙乌地阿拉伯气喘倡议、沙乌地阿拉伯胸腔科学会。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：MEA 呼吸道感染治疗市场格局

  • 概述
  • PEST分析

第 5 章：MEA 呼吸道感染治疗市场 - 主要市场动态

  • MEA 呼吸道感染治疗市场 - 主要市场动态
  • 主要市场驱动因素
    • 中东呼吸道感染病例不断增加
    • 提高对呼吸道感染的认识
  • 主要市场限制
    • 缺乏针对呼吸治疗的研究
  • 主要市场机会
    • 治疗呼吸道感染的非处方药产品需求激增
  • 未来的趋势
    • MERS 抗病毒治疗的出现
  • 驱动因素和限制的影响：

第 6 章：MEA 呼吸道感染治疗市场分析

  • MEA 呼吸道感染治疗市场收入，2023-2031

第 7 章：MEA 呼吸道感染治疗市场分析 - 按药物

  • 抗生素
  • 非类固醇抗发炎药
  • 止咳药
  • 鼻减充血剂

第 8 章：MEA 呼吸道感染治疗市场分析 - 依疾病适应症

  • 下呼吸道感染
  • 上呼吸道感染

第 9 章：MEA 呼吸道感染治疗市场分析 - 按给药途径

  • 口服
  • 注射用

第 10 章：MEA 呼吸道感染治疗市场分析 - 按年龄组

  • 儿科
  • 成年人

第 11 章：MEA 呼吸道感染治疗市场分析 - 按配销通路

  • 医院药房
  • 零售药局
  • 网路药局

第 12 章：MEA 呼吸道感染治疗市场 - 国家分析

  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • MEA 的其余部分
    • MEA 的其余部分

第 13 章：公司简介

  • Abbott Laboratories
  • Teva Pharmaceutical Industries Ltd
  • Sanofi SA
  • Boehringer Ingelheim International GmbH
  • AstraZeneca Plc
  • Alembic Pharmaceuticals Ltd
  • GSK Plc
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Gulf Pharmaceutical Industries Co

第 14 章：附录

Product Code: TIPRE00038996

The MEA respiratory tract infection treatment market size is expected to grow from US$ 2.09 billion in 2023 to US$ 2.97 billion by 2031; it is estimated to register a CAGR of 4.50% from 2023 to 2031.

Surge in Demand for OTC Products to Treat Respiratory Infections Opportunity for Growth of MEA Respiratory Tract Infection Treatment Market

A vast number of consumers seek accessible and convenient solutions for common respiratory symptoms such as cough, congestion, and sore throat. This approach empowers individuals who are not suffering from life-threatening diseases to closely monitor and control their health. It also allows manufacturers, pharmacies, and healthcare providers to make their product offerings more suitable for over-the-counter (OTC) applications, educate consumers on self-care practices, and improve access to treatment options providing relief from various symptoms. The burgeoning popularity of OTC respiratory remedies underlines the importance of promoting respiratory health awareness, fostering self-management strategies and a collaborative healthcare ecosystem. By leveraging the rising popularity of OTC respiratory products, the respiratory tract infection treatment market stakeholders in the MEA can enhance patient engagement, promote preventive healthcare measures, and address the evolving healthcare needs of diverse populations. Thus, the increasing demand for OTC products to manage respiratory infections represents a significant opportunity for the MEA respiratory tract infection treatment market.

Drug -Based Insights

In terms of drug, the antibiotics segment held the largest MEA respiratory tract infection treatment market share in 2023. The same is anticipated to register the highest CAGR during 2023-2031. Respiratory tract infections encompass a range of ailments, including bronchitis, pneumonia, and sinusitis, often caused by bacterial pathogens.

Disease Indication -Based Insights

Based on disease indication, the lower respiratory tract infection segment held a larger market share in 2023. It is further anticipated to register a higher CAGR from 2023 to 2031. Lower respiratory tract infections (LRTIs) are infections that affect the lungs and bronchial tubes, typically caused by bacterial, viral, or fungal pathogens, among others.

Route Of Administration -Based Insights

By route of administration, the oral segment held a larger share of the MEA respiratory tract infection treatment market; the same segment is anticipated to register a higher CAGR during 2023-2031. Oral antibiotics such as amoxicillin, azithromycin, or doxycycline are frequently prescribed to combat bacterial pathogens causing respiratory tract infections.

Age Group -Based Insights

In terms of age group, the adult segment held a larger share of the MEA respiratory tract infection treatment market in 2023. The pediatrics segment is anticipated to register a higher CAGR during 2023-2031. The high prevalence of respiratory tract infections among children is a key factor driving the need for effective treatment options.

Distribution Channel -Based Insights

In terms of distribution channel, the hospital pharmacies segment is anticipated to account for a significant market share during 2023-2031. Hospital pharmacies serve as key components of a healthcare system; they particularly play a vital role in the management of acute and severe respiratory tract infections, which require intravenous or intramuscular administration of medications.

A few of the major primary and secondary sources referred to while preparing the report on the MEA respiratory tract infection treatment market are the Dubai Health Authority, Saudi Initiative for Asthma, Saudi Thoracic Society.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. MEA Respiratory Tract Infection Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. MEA Respiratory Tract Infection Treatment Market - Key Market Dynamics

  • 5.1 MEA Respiratory Tract Infection Treatment Market - Key Market Dynamics
  • 5.2 Key Market Drivers
    • 5.2.1 Rising Cases of Respiratory Infections in Middle East
    • 5.2.2 Increasing Awareness Related to Respiratory Tract Infections
  • 5.3 Key Market Restraints
    • 5.3.1 Lack of Research Focused on Respiratory Therapeutics
  • 5.4 Key Market Opportunities
    • 5.4.1 Surge in Demand for OTC Products to Treat Respiratory Infections
  • 5.5 Future Trends
    • 5.5.1 Advent of Antiviral Treatment for MERS
  • 5.6 Impact of Drivers and Restraints:

6. MEA Respiratory Tract Infection Treatment Market Analysis

  • 6.1 MEA Respiratory Tract Infection Treatment Market Revenue (US$ Million), 2023-2031

7. MEA Respiratory Tract Infection Treatment Market Analysis - by Drugs

  • 7.1 Antibiotics
    • 7.1.1 Overview
    • 7.1.2 Antibiotics: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 NSAIDs
    • 7.2.1 Overview
    • 7.2.2 NSAIDs: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Cough Suppressants
    • 7.3.1 Overview
    • 7.3.2 Cough Suppressants: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Nasal Decongestants
    • 7.4.1 Overview
    • 7.4.2 Nasal Decongestants: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

8. MEA Respiratory Tract Infection Treatment Market Analysis - by Disease Indication

  • 8.1 Lower Respiratory Tract Infection
    • 8.1.1 Overview
    • 8.1.2 Lower Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Upper Respiratory Tract Infection
    • 8.2.1 Overview
    • 8.2.2 Upper Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

9. MEA Respiratory Tract Infection Treatment Market Analysis - by Route Of Administration

  • 9.1 Oral
    • 9.1.1 Overview
    • 9.1.2 Oral: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Parenteral
    • 9.2.1 Overview
    • 9.2.2 Parenteral: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

10. MEA Respiratory Tract Infection Treatment Market Analysis - by Age Group

  • 10.1 Pediatrics
    • 10.1.1 Overview
    • 10.1.2 Pediatrics: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Adults
    • 10.2.1 Overview
    • 10.2.2 Adults: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

11. MEA Respiratory Tract Infection Treatment Market Analysis - by Distribution Channel

  • 11.1 Hospital Pharmacies
    • 11.1.1 Overview
    • 11.1.2 Hospital Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Retail Pharmacies
    • 11.2.1 Overview
    • 11.2.2 Retail Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Online Pharmacies
    • 11.3.1 Overview
    • 11.3.2 Online Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12. MEA Respiratory Tract Infection Treatment Market - Country Analysis

  • 12.1 Middle East and Africa
    • 12.1.1 MEA Respiratory Tract Infection Treatment Market Breakdown by Countries
    • 12.1.2 MEA Respiratory Tract Infection Treatment Market Revenue and Forecast and Analysis - by Country
    • 12.1.3 MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2030
      • 12.1.3.1 MEA Respiratory Tract Infection Treatment Market Revenue and Forecast and Analysis - by Country
      • 12.1.3.2 Saudi Arabia
      • 12.1.3.3 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.3.3.1 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs
        • 12.1.3.3.2 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication
        • 12.1.3.3.3 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration
        • 12.1.3.3.4 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group
        • 12.1.3.3.5 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel
      • 12.1.3.4 South Africa
      • 12.1.3.5 South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.3.5.1 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs
        • 12.1.3.5.2 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication
        • 12.1.3.5.3 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration
        • 12.1.3.5.4 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group
        • 12.1.3.5.5 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel
      • 12.1.3.6 UAE
      • 12.1.3.7 UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.3.7.1 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs
        • 12.1.3.7.2 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication
        • 12.1.3.7.3 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration
        • 12.1.3.7.4 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group
        • 12.1.3.7.5 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel
      • 12.1.3.8 Rest of MEA
      • 12.1.3.9 REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.3.9.1 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs
        • 12.1.3.9.2 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication
        • 12.1.3.9.3 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration
        • 12.1.3.9.4 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group
        • 12.1.3.9.5 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Teva Pharmaceutical Industries Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Sanofi SA
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Boehringer Ingelheim International GmbH
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 AstraZeneca Plc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Alembic Pharmaceuticals Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 GSK Plc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Novartis AG
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 F. Hoffmann-La Roche Ltd
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Gulf Pharmaceutical Industries Co
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. MEA Respiratory Tract Infection Treatment Market Segmentation
  • Table 2. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs
  • Table 3. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication
  • Table 4. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 5. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group
  • Table 6. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 7. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Country
  • Table 8. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs
  • Table 9. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication
  • Table 10. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 11. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group
  • Table 12. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 13. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs
  • Table 14. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication
  • Table 15. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 16. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group
  • Table 17. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 18. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs
  • Table 19. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication
  • Table 20. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 21. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group
  • Table 22. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 23. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs
  • Table 24. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication
  • Table 25. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 26. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group
  • Table 27. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 28. Glossary of Terms, MEA Respiratory Tract Infection Treatment Market

List Of Figures

  • Figure 1. MEA Respiratory Tract Infection Treatment Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. MEA Respiratory Tract Infection Treatment Market Revenue (US$ Million), 2023-2031
  • Figure 5. MEA Respiratory Tract Infection Treatment Market Share (%) - by Drugs, 2023 and 2031
  • Figure 6. Antibiotics: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. NSAIDs: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Cough Suppressants: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Nasal Decongestants: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. MEA Respiratory Tract Infection Treatment Market Share (%) - by Disease Indication, 2023 and 2031
  • Figure 11. Lower Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Upper Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. MEA Respiratory Tract Infection Treatment Market Share (%) - by Route Of Administration, 2023 and 2031
  • Figure 14. Oral: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Parenteral: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. MEA Respiratory Tract Infection Treatment Market Share (%) - by Age Group, 2023 and 2031
  • Figure 17. Pediatrics: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Adults: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. MEA Respiratory Tract Infection Treatment Market Share (%) - by Distribution Channel, 2023 and 2031
  • Figure 20. Hospital Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Retail Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Online Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. MEA Respiratory Tract Infection Treatment Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 24. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 25. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)